Latest Ipsen S.A. ADR (IPSEY) Headlines Ipsen
Post# of 6
Posted On: 03/10/2014 6:58:33 AM
Latest Ipsen S.A. ADR (IPSEY) Headlines
Ipsen's net profit up by 6.4% in H1 2013
M2 - Fri Aug 30, 7:59AM CDT
Ipsen SA (Euronext: IPN) (Paris: IPN.PA), a specialty-driven pharmaceutical company, on Friday reported consolidated net profit attributable to shareholders of EUR96.2m, or diluted EPS of EUR1.15, for the first half 2013, ended 30 June 2013.
Baxter closes deal for potential hemophilia drug
By The Associated Press - AP - Thu Mar 21, 8:39AM CDT
Baxter International Inc. has closed its acquisition of a potential hemophilia treatment from the French drugmaker Ipsen and Inspiration Biopharmaceuticals Inc. in a deal that could be worth more than $180 million.
Ipsen's net profit up by 6.4% in H1 2013
M2 - Fri Aug 30, 7:59AM CDT
Ipsen SA (Euronext: IPN) (Paris: IPN.PA), a specialty-driven pharmaceutical company, on Friday reported consolidated net profit attributable to shareholders of EUR96.2m, or diluted EPS of EUR1.15, for the first half 2013, ended 30 June 2013.
Baxter closes deal for potential hemophilia drug
By The Associated Press - AP - Thu Mar 21, 8:39AM CDT
Baxter International Inc. has closed its acquisition of a potential hemophilia treatment from the French drugmaker Ipsen and Inspiration Biopharmaceuticals Inc. in a deal that could be worth more than $180 million.
(0)
(0)Ipsen S.A. (IPSEY) Stock Research Links
Scroll down for more posts ▼